SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

PLoS One. 2014;9(1):e84052.

Relationship between changes in body fat and a decline of renal function in the elderly.

, , , , , , , ,

제1저자 오세원 · 교신저자 진호준

소속 (6)
  1. Department of Internal Medicine, Eulji General Hospital, Eulji University College of Medicine, Seoul, Korea.
  2. Department of Internal Medicine, Seoul National University Bundang Hospital, Kyeong-Kido, Korea ; Department of Internal Medicine, Seoul National University, Seoul, Korea.
  3. Department of Internal Medicine, Seoul National University Bundang Hospital, Kyeong-Kido, Korea.
  4. Department of Psychiatry, Seoul National University College of Medicine, Seoul, Korea.
  5. Department of Internal Medicine, Seoul National University, Seoul, Korea ; Renal Institute, Seoul National University Medical Research Center, Seoul, Korea.
  6. Department of Internal Medicine, Seoul National University Bundang Hospital, Kyeong-Kido, Korea ; Department of Internal Medicine, Seoul National University, Seoul, Korea ; Renal Institute, Seoul National University Medical Research Center, Seoul, Korea.

Abstract

Obesity is a risk factor for chronic kidney disease, and its prevalence among the elderly is increasing. We investigated the effects of changes in body fat percentage (BFP) on the longitudinal changes in the estimated glomerular filtration rate (eGFR) in the elderly. This prospective cohort study included 390 participants aged >65 years who underwent bioelectrical impedance analysis at baseline and follow-up as a part of the Korean Longitudinal Study on Health and Aging. After a median follow-up period of 5.3 years, BFP was significantly higher than that at the start point (P<0.05). Participants who had the largest increase in BFP had the highest BMI and waist circumference (WC) (P<0.001). The highest tertile had the highest white blood cell count and erythrocyte sedimentation rate, incidence of rapid progression, and decline in eGFR >25% (P≤0.017, P = 0.025, P = 0.005, respectively). The lowest tertile had the lowest triglyceride and highest high-density lipoprotein levels (P<0.05). The adjusted decline rate in eGFR was correlated with a change in BFP (P = 0.039), but not with that in BMI or WC. The highest tertile had a 4.875-fold increase in the risk for rapid progression to a decline in eGFR (95% CI: 1.366-17.397) and a 4.931-fold decrease in the risk to a decline in eGFR>25% (95% CI: 1.617-15.037), when compared with the lowest tertile. In subgroup analysis, the incidence of renal outcomes was significantly increased according to the increase in BFP in patients with lower eGFR (P≤0.010). A change in BFP may be associated with inflammation and dyslipidemia development, and longitudinal changes in body fat are related to a decrease in eGFR in the elderly.

Figures

Figure 1
Figure 1 Identification of study participants.
Figure 2
Figure 2 Annual decline in eGFR is correlated with change of body fat. (A) Unadjusted annual decline in eGFR amongst tertiles of change in body fat percentage. (B) Adjusted annual decline in eGFR among tertiles of change in body fat percentage. (C) Adjusted annual decline in eGFR among tertiles of change in BMI. (D) Adjusted annual decline in eGFR among tertiles change of waist circumference. Error bars indicate standard error of mean. Annual decline in eGFR was adjusted using analysis of covariance (ANCOVA) by age; sex; diabetes; hypertension; smoking history; and baseline values of systolic blood pressure, fasting glucose, body mass index, serum creatinine, triglyceride, high-density lipoprotein.
Figure 3
Figure 3 The incidence of renal outcome according to the changes of body fat. (A) The incidence of rapid renal according to the increase in body fat percent in participants with lower eGFR and higher eGFR . (B) The incidence of decline in eGFR>25% according to the increase in body fat percent in participants with lower eGFR and higher eGFR.

그림 출처: PubMed Central 공개 논문 (PMC3894176)

Conflict of interest statement

Competing Interests:This work was partly supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
PloS one · eISSN 1932-6203
전자 출판
2014-01-16
MeSH
Aged · Aging · Body Fat Distribution* · Female · Glomerular Filtration Rate · Humans · Kidney / physiopathology · Male · Prospective Studies · Waist-Hip Ratio
참고문헌
40편